OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
6730$35.9054

Lagis Enterprise Co Ltd

Medical Equipment, Supplies & DistributionVerified

Lagis Enterprise Co Ltd has a market capitalization of TWD 1,303,098,200 and a market price of TWD 35.9 per share, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and returns are not available for comparison against industry_config preferred metrics or cohort medians, as no relevant financial ratios or performance indicators are provided in the valuation snapshot. This limits the ability to assess its performance relative to industry benchmarks. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to evaluate revenue concentration or geographic diversification. Without this information, the company's exposure to regional economic or regulatory risks cannot be determined. Growth trajectory data is also not available, as no outlook numeric deltas or revenue history are provided in the input data. This limits the ability to assess the company's future performance or growth potential. The risk assessment indicates a low dilution potential, with no immediate dilution pressure from new share issuance or convertible instruments. However, liquidity risk remains unassessed due to the lack of balance-sheet inputs and no going-concern language in source documents. Recent events, such as filings or transcripts, are not disclosed in the available source documents, preventing an analysis of the company's recent developments or strategic direction.

30-day price · 6730+0.80 (+2.2%)
Low$36.70High$39.20Close$37.80As of21 May, 00:00 UTC
Profile
CompanyLagis Enterprise Co Ltd
Ticker6730.TWO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Lagis Enterprise Co Ltd operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Classification. Lagis Enterprise Co Ltd is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Lagis Enterprise Co Ltd has a market capitalization of TWD 1,303,098,200 and a market price of TWD 35.9 per share, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and returns are not available for comparison against industry_config preferred metrics or cohort medians, as no relevant financial ratios or performance indicators are provided in the valuation snapshot. This limits the ability to assess its performance relative to industry benchmarks. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to evaluate revenue concentration or geographic diversification. Without this information, the company's exposure to regional economic or regulatory risks cannot be determined. Growth trajectory data is also not available, as no outlook numeric deltas or revenue history are provided in the input data. This limits the ability to assess the company's future performance or growth potential. The risk assessment indicates a low dilution potential, with no immediate dilution pressure from new share issuance or convertible instruments. However, liquidity risk remains unassessed due to the lack of balance-sheet inputs and no going-concern language in source documents. Recent events, such as filings or transcripts, are not disclosed in the available source documents, preventing an analysis of the company's recent developments or strategic direction.
Key takeaways
  • Lagis Enterprise Co Ltd has no difference between basic and diluted shares outstanding, indicating no immediate dilution risk.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • Profitability and returns data are not available for comparison against industry benchmarks.
  • Segment and geographic exposure data are not disclosed, limiting the ability to evaluate revenue concentration or geographic diversification.
  • Growth trajectory data is not available, as no outlook numeric deltas or revenue history are provided.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$393.0M$64.8M$48.9M$28.4M
FY-3$442.2M$81.7M$71.0M$972.0k
FY-2$459.9M$77.1M$64.1M-$187.3M
FY-1$454.4M$81.2M$68.2M-$208.3M
FY0$487.6M$87.9M$69.3M-$12.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$594.1M$495.2M
FY-3$658.8M$534.3M
FY-2$845.4M$540.8M
FY-1$1.09B$579.8M
FY0$1.14B$762.0M
PeriodOCFCapExFCFSBC
FY-4$96.2M-$26.0M$28.4M
FY-3$84.3M-$69.9M$972.0k
FY-2$77.5M-$226.0M-$187.3M
FY-1$74.1M-$276.1M-$208.3M
FY0$131.7M-$92.0M-$12.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3$115.7M$20.1M$17.3M-$7.1M
FQ-2$121.6M$24.8M$15.4M-$8.3M
FQ-1$126.4M$24.4M$20.4M$10.9M
FQ0$123.9M$18.5M$16.2M$24.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3$1.11B$565.0M
FQ-2$1.11B$580.4M
FQ-1$1.12B$604.8M
FQ0$1.14B$762.0M
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3$9.8M-$32.2M-$7.1M
FQ-2$49.8M-$65.0M-$8.3M
FQ-1$83.6M-$86.7M$10.9M
FQ0$131.7M-$92.0M$24.9M
Valuation
Market price$35.90
Market cap$1.30B
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
Metric6730Activity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity17.9% medp25 2.7% · p75 52.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:48 UTC#1c3c1d8a
Market quoteclose TWD 37.50 · shares 0.04B diluted
no public URL
2026-05-12 00:48 UTC#ea5149f8
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:07 UTCJob: 28595e72